Metabolic reprogramming of normal oral fibroblasts correlated with increased glycolytic metabolism of oral squamous cell carcinoma and precedes their activation into carcinoma associated fibroblasts

[1]  R. Summer,et al.  Metabolic Reprogramming as a Driver of Fibroblast Activation in PulmonaryFibrosis , 2019, The American journal of the medical sciences.

[2]  J. Neuzil,et al.  Mitochondrial Genome Transfer to Tumor Cells Breaks The Rules and Establishes a New Precedent in Cancer Biology , 2018, Molecular & cellular oncology.

[3]  E. Ma,et al.  AMPK Maintains Cellular Metabolic Homeostasis through Regulation of Mitochondrial Reactive Oxygen Species. , 2017, Cell reports.

[4]  U. Martinez-outschoorn,et al.  Metabolic coupling and the Reverse Warburg Effect in cancer: Implications for novel biomarker and anticancer agent development. , 2017, Seminars in oncology.

[5]  G. Bourque,et al.  The PGC-1α/ERRα Axis Represses One-Carbon Metabolism and Promotes Sensitivity to Anti-folate Therapy in Breast Cancer. , 2016, Cell reports.

[6]  M. Therkildsen,et al.  A reverse Warburg metabolism in oral squamous cell carcinoma is not dependent upon myofibroblasts. , 2015, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.

[7]  K. Griffith,et al.  Caveolin-1 is Associated with Tumor Progression and Confers a Multi-Modality Resistance Phenotype in Pancreatic Cancer , 2015, Scientific Reports.

[8]  R. Parton,et al.  Critical role of CAV1/caveolin-1 in cell stress responses in human breast cancer cells via modulation of lysosomal function and autophagy , 2015, Autophagy.

[9]  R. Mohney,et al.  Senescent human fibroblasts show increased glycolysis and redox homeostasis with extracellular metabolomes that overlap with those of irreparable DNA damage, aging, and disease. , 2015, Journal of proteome research.

[10]  T. Salo,et al.  Caveolin-1 accumulation in the tongue cancer tumor microenvironment is significantly associated with poor prognosis: an in-vivo and in-vitro study , 2015, BMC Cancer.

[11]  S. Sollott,et al.  Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. , 2014, Physiological reviews.

[12]  Xi Chen,et al.  Loss of Stromal Caveolin-1 Expression: A Novel Tumor Microenvironment Biomarker That Can Predict Poor Clinical Outcomes for Pancreatic Cancer , 2014, PloS one.

[13]  M. Brentani,et al.  Markers of breast cancer stromal fibroblasts in the primary tumour site associated with lymph node metastasis: a systematic review including our case series , 2013, Bioscience reports.

[14]  G. Kalna,et al.  Identification of two distinct carcinoma-associated fibroblast subtypes with differential tumor-promoting abilities in oral squamous cell carcinoma. , 2013, Cancer research.

[15]  G. Thomas,et al.  Progression of genotype-specific oral cancer leads to senescence of cancer-associated fibroblasts and is mediated by oxidative stress and TGF-β. , 2013, Carcinogenesis.

[16]  S. Rafii,et al.  Preferential transfer of mitochondria from endothelial to cancer cells through tunneling nanotubes modulates chemoresistance , 2013, Journal of Translational Medicine.

[17]  Zonghuan Li,et al.  Caveolin-1 Expression Level in Cancer Associated Fibroblasts Predicts Outcome in Gastric Cancer , 2013, PloS one.

[18]  S. Andò,et al.  CDK inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, “fueling” tumor growth via paracrine interactions, without an increase in neo-angiogenesis , 2012, Cell cycle.

[19]  V. Patel,et al.  mTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. , 2012, Cell stem cell.

[20]  S. Chi,et al.  Caveolin-1 increases aerobic glycolysis in colorectal cancers by stimulating HMGA1-mediated GLUT3 transcription. , 2012, Cancer research.

[21]  F. Sotgia,et al.  Warburg meets autophagy: cancer-associated fibroblasts accelerate tumor growth and metastasis via oxidative stress, mitophagy, and aerobic glycolysis. , 2012, Antioxidants & redox signaling.

[22]  R. Mohney,et al.  Oncogene-induced senescence results in marked metabolic and bioenergetic alterations , 2012, Cell cycle.

[23]  N. Johnson,et al.  Squamous cell carcinoma and precursor lesions of the oral cavity: epidemiology and aetiology. , 2011, Periodontology 2000.

[24]  Adam Ertel,et al.  Evidence for a stromal-epithelial “lactate shuttle” in human tumors , 2011, Cell cycle.

[25]  Judith Campisi,et al.  Senescent cells as a source of inflammatory factors for tumor progression , 2010, Cancer and Metastasis Reviews.

[26]  P. Fortina,et al.  The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma , 2009, Cell cycle.

[27]  Matthias Schäfer,et al.  Cancer as an overhealing wound: an old hypothesis revisited , 2008, Nature Reviews Molecular Cell Biology.

[28]  A. Rosenberg,et al.  Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 down-regulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy , 2008, Cancer biology & therapy.

[29]  G. Mills,et al.  The chemokine growth-regulated oncogene 1 (Gro-1) links RAS signaling to the senescence of stromal fibroblasts and ovarian tumorigenesis , 2006, Proceedings of the National Academy of Sciences.

[30]  Jiandie D. Lin,et al.  Suppression of Reactive Oxygen Species and Neurodegeneration by the PGC-1 Transcriptional Coactivators , 2006, Cell.

[31]  E. Rosenthal,et al.  Elevated expression of TGF‐β1 in head and neck cancer–associated fibroblasts , 2004, Molecular carcinogenesis.

[32]  P. Speight,et al.  Tumour-derived TGF-β1 modulates myofibroblast differentiation and promotes HGF/SF-dependent invasion of squamous carcinoma cells , 2004, British Journal of Cancer.

[33]  J. Campisi,et al.  Senescent fibroblasts promote epithelial cell growth and tumorigenesis: A link between cancer and aging , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[34]  S. Bröer,et al.  The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. , 2000, The Biochemical journal.